会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • MOBILE DEVICE CASE WITH RETRACTOR REEL ASSEMBLY FOR USER-PROVIDED HEADPHONES
    • 住房与用户的卷筒组装耳机移动设备
    • EP3085266A1
    • 2016-10-26
    • EP16168493.1
    • 2012-09-24
    • Koenig, ScottConroy, David
    • Koenig, ScottConroy, David
    • A45C11/00H04B1/38H01R13/72H02G11/02H04M1/15B65H75/44
    • H05K5/0247B65H75/4431B65H75/4449B65H2701/3919H01R13/72H02G11/02H04M1/15H04R1/1033H05K5/0217
    • A mobile device case (100) includes a reel assembly, including a reel (105), a supporting plate (110), and a hub (108) between the reel and the supporting plate. The hub includes a first cavity between the hub and the supporting plate for housing a spring (109), and a second cavity between the hub and the reel for housing a flat flexible cable (106) (FFC). The spring is wound in a first direction, while the FFC is wound in a second direction. The FFC includes a first end for electrically coupling to a female jack connector (119) of a device. A female connector (107) is electrically coupled to a second end of the FFC for engaging a male jack connector of user-provided headphones (116). When the reel (105) rotates in the first direction, the spring (109) tightens and the FFC loosens. When the reel (105) rotates in the second direction, the spring (109) loosens and the FFC tightens.
    • 的移动设备的情况下(100)包括一个卷轴组件,包括一个带盘(105),支撑板(110)和所述卷轴和所述支承板之间的轮毂(108)。 轮毂包括毂和用于容纳弹簧(109)的支撑板,和轮毂之间的第二腔体和用于容纳扁平柔性电缆(106)的卷轴(FFC)之间的第一腔。 该弹簧被卷绕在第一方向上,而FFC被在第二方向上缠绕。 的FFC包括用于电耦合的第一端连接到装置的阴插座连接器(119)。 的阴连接器(107)电耦合到所述FFC的第二端,用于接合用户提供的耳机(116)的阳连接器插孔。 当卷轴(105)在第一方向上旋转时,弹簧(109)拧紧和松开FFC。 当卷轴(105)在第二方向上旋转时,弹簧(109)松开和收紧FFC。
    • 7. 发明申请
    • METHODS FOR THE TREATMENT OF DISEASE USING IMMUNOGLOBULINS HAVING FC REGIONS WITH ALTERED AFFINITIES FOR FCγR ACTIVATING AND FCγR INHIBITING
    • 使用具有更改功能的FC区域的免疫球蛋白治疗疾病的方法用于FC?R激活和FC?R抑制
    • WO2008140603A2
    • 2008-11-20
    • PCT/US2007/086793
    • 2007-12-07
    • MACROGENICS, INC.STAVENHAGEN, Jeffrey, B.KOENIG, Scott
    • STAVENHAGEN, Jeffrey, B.KOENIG, Scott
    • A61K39/395C07K16/28C07K16/24
    • C07K16/30A61K2039/505C07K16/2887C07K2317/71C07K2317/72C07K2317/732C07K2317/734
    • The present invention relates to methods of treating or preventing cancer and other diseases using molecules, particularly polypeptides, more particularly immunoglobulins ( e.g ., antibodies), comprising a variant Fc region, wherein said variant Fc region comprises at least one amino acid modification relative to a wild-type Fc region, which variant Fc region binds an FcγR that activates a cellular effector ("FcγR activating ," such as FcγRIIA or FcγRIIIA) and an FcγR that inhibits a cellular effector ("FcγR inhibiting " such as FcγRIIA) with an altered Ratio of Affinities relative to the respective binding affinities of such FcγR for the Fc region of the wild-type immunoglobulin. The methods of the invention are particularly useful in preventing, treating, or ameliorating one or more symptoms associated with a disease, disorder, or infection where either an enhanced efficacy of effector cell function mediated by FcγR is desired ( e.g ., cancer, infectious disease) or an inhibited effector cell response mediated by FcγR is desired ( e.g ., inflammation, autoimmunde disease).
    • 本发明涉及使用分子,特别是多肽,特别是包含变体Fc区的免疫球蛋白(例如抗体)治疗或预防癌症和其它疾病的方法,其中所述变体Fc区包含至少一个相对于 野生型Fc区,该变体Fc区结合激活细胞效应子(“FcγRIIA活化”,例如FcγRIIA或FcγRIIIA)的FcγR和FcγR 其具有相对于野生型Fc区的Fc区的这种FcγR的各自结合亲和力的改变的亲和力比例抑制细胞效应子(“FcαRα抑制”如FcγRIIA) 型免疫球蛋白。 本发明的方法特别可用于预防,治疗或改善与需要由FcγR介导的效应细胞功能的增强功效的疾病,病症或感染相关的一种或多种症状(例如,癌症,感染性 疾病)或由FcγR介导的受抑制的效应细胞应答是期望的(例如炎症,自身免疫疾病)。